The Diabetes Control and Complications Trial: new challenges for the primary physician.
Clarke
W L
WL
Division of Pediatric Endocrinology, University of Virginia Health Sciences Center, Charlottesville.
D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000032:analysis* / Q000187:drug effects; D003362:Cost-Benefit Analysis; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D003928:Diabetic Nephropathies / Q000517:prevention & control; D003929:Diabetic Neuropathies / Q000517:prevention & control; D003930:Diabetic Retinopathy / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D004502:Education, Medical, Continuing; D005194:Family Practice / Q000193:education; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007275:Injections, Intravenous; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects; D007332:Insulin Infusion Systems; D008297:Male; D009042:Motivation; D010348:Patient Care Team; D010353:Patient Education as Topic; D011320:Primary Health Care / Q000191:economics / Q000379:methods
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007328:Insulin